litlas
Log inCreate account

Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial

Authors: Roberto Ferrari, Ian Ford, Kim Fox, Jean Pascal Challeton, Anne Correges, Michał Tendera, Petr Widimský, Nicolas Danchin - The Lancet 2020 cited by 75

Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial | Litlas